The Core Ultrasound Applications for Nurse Practitioners

September 16, 2025 updated by: National Taiwan University Hospital

The Development and Assessment of the Core Ultrasound Applications for Nurse Practitioners in Taiwan

This project aims to establish point-of-care ultrasound (PoCUS) training course for nurse practitioners in Taiwan, and standardized evaluation modules. The study subjects are nurse practitioners across different hospital levels.

I

Study Overview

Status

Active, not recruiting

Conditions

Intervention / Treatment

Detailed Description

This project aims to establish point-of-care ultrasound (PoCUS) training course for nurse practitioners in Taiwan, and standardized evaluation modules. The study subjects are nurse practitioners across different hospital levels.

Study Type

Observational

Enrollment (Estimated)

150

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Taiwan
    • Taiwan
      • Taipei, Taiwan, Taiwan, 100
        • Wan-Ching Lien

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

N/A

Sampling Method

Non-Probability Sample

Study Population

nursing practitioners

Description

Inclusion Criteria:

nursing practitioners who are interested in PoCUS.

Exclusion Criteria:

nursing practitioners who are not interested in PoCUS.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
written test
Time Frame: 1day
10 multi-choice questionaire
1day
hands-on performance
Time Frame: 1 day
using 5-point Likert scale. Point 1 indicated no recognizable structures; point 2 indicated minimally recognizable structures but insufficient for diagnosis; point 3 indicated minimal criteria met for diagnosis, recognizable structures but with some technical flaws; point 4 indicated all structures imaged well and diagnosis easily supported; point 5 indicated all structures imaged with excellent image quality and diagnosis completely supported
1 day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
written test at the 3-month assessment
Time Frame: 3 months
10 multi-choice questionaire
3 months
hands-on performance at the 3-month assessment
Time Frame: 3 months
using 5-point Likert scale. Point 1 indicated no recognizable structures; point 2 indicated minimally recognizable structures but insufficient for diagnosis; point 3 indicated minimal criteria met for diagnosis, recognizable structures but with some technical flaws; point 4 indicated all structures imaged well and diagnosis easily supported; point 5 indicated all structures imaged with excellent image quality and diagnosis completely supported
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

National Taiwan University Hospital

Investigators

  • Principal Investigator: Wan-Ching Lien, NTUH

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2022

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Study Registration Dates

First Submitted

July 25, 2024

First Submitted That Met QC Criteria

August 4, 2024

First Posted (Actual)

August 9, 2024

Study Record Updates

Last Update Posted (Actual)

September 22, 2025

Last Update Submitted That Met QC Criteria

September 16, 2025

Last Verified

September 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 202112120RINB

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Immediate and 3-month Assessment of PoCUS Performance

Clinical Trials on ultrasound training

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mozambique

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe